Yuvraj

Abbott Named One of the “Top Employers” in the Biotech and Pharmaceutical Industry by Science Magazine

Abbott Park, Illinois was named one of the top 20 employers in Science magazine's 2010 Top Biopharma Employers survey. The annual survey seeks to...

Scripps Research Study Challenges Conventional Theory of Modern Drug Design

Scientists from The Scripps Research Institute have uncovered new evidence that challenges the current theory about a process key to the way modern drugs...

Novartis announces agreement to develop influenza vaccines using revolutionary synthetic genomics technology

Novartis announced today an agreement with Synthetic Genomics Vaccines Inc. (SGVI) to apply "synthetic genomics" technologies to accelerate the production of the influenza seed...

Amgen announced that results from the PRIME ‘203’ and ‘181’ pivotal Phase 3 trials

Amgen announced that results from the PRIME '203' and '181' pivotal Phase 3 trials evaluating Vectibix(R) (panitumumab) in combination with chemotherapy (FOLFOX or FOLFIRI)...

Lupin Announces Final FDA Approval of Generic Hyzaar® and Cozaar

Pharma Major, Lupin Limited announced that its U.S subsidiary, Lupin Pharmaceuticals, Inc. (LPI) has been granted final approval for the company's generic versions of...

AJ Precision Components to Exhibit at Interplas 2011

AJ Precision Components will be exhibiting at Interplas 2011 from 27 to 29 September. Come and visit us on stand A58 in hall...

APR and Labtec enter into exclusive License Agreement with Ferrer International

APR and its development partner Labtec have entered into an exclusive licensing agreement with the leading European pharmaceutical company Ferrer Internacional (Ferrer) for the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read